Investigación / Grupos de investigación

Grupo  603

Genética y Clínica de las Neoplasias Hematológicas y el Trasplante Hematopoyético

Publicaciones (594)

  • Sanz, J; Picardi, A; Boluda, JCH; Martin, C; Ferra, C; Nozzoli, C; Gonzalez-Vicent, M; Rambaldi, A; Valcarcel, D; Verdeguer, A; Serrano, D; de Heredia, CD; Pascual, MJ; de Paz, R; Montesinos, P; Bartolozzi, B; Algarotti, A; Sanz, MA; Arcese, W; Sanz, GF.

    Impact of Graft-versus-Host Disease Prophylaxis on Outcomes after Myeloablative Single-Unit Umbilical Cord Blood Transplantation

    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2013; 19(9): 1387-1392 Nº de citas: 20 [doi:10.1016/j.bbmt.2013.07.004]

  • Rodriguez-Macias, G; Martinez-Laperche, C; Gayoso, J; Noriega, V; Serrano, D; Balsalobre, P; Munoz-Martinez, C; Diez-Martin, JL; Buno, I.

    Mutation of the NPM1 gene contributes to the development of donor cell-derived acute myeloid leukemia after unrelated cord blood transplantation for acute lymphoblastic leukemia

    HUMAN PATHOLOGY. 2013; 44(8): 1696-1699 Nº de citas: 11 [doi:10.1016/j.humpath.2013.01.001]

  • Perez, AP; Lopez, FC; Simoneau, DS; Nofuentes, PB; Fernandez, RS.

    Abdominal necrotic plaque in an immunocompromised patient

    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY. 2013; 69(2): [doi:10.1016/j.jaad.2012.11.041]

  • Caballero-Velazquez, T; Lopez-Corral, L; Encinas, C; Castilla-Llorente, C; Martino, R; Rosinol, L; Sampol, A; Caballero, D; Serrano, D; Heras, I; San Miguel, J; Perez-Simon, JA.

    Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients

    BRITISH JOURNAL OF HAEMATOLOGY. 2013; 162(4): 474-482 Nº de citas: 39 [doi:10.1111/bjh.12410]

  • Sanchez-Espiridion, B; Martin-Moreno, AM; Montalban, C; Figueroa, V; Vega, F; Younes, A; Medeiros, LJ; Alves, FJ; Canales, M; Estevez, M; Menarguez, J; Sabin, P; Ruiz-Marcellan, MC; Lopez, A; Sanchez-Godoy, P; Burgos, F; Santonja, C; Lopez, JL; Piris, MA; Garcia, JF.

    MicroRNA signatures and treatment response in patients with advanced classical Hodgkin lymphoma

    BRITISH JOURNAL OF HAEMATOLOGY. 2013; 162(3): 336-347 Nº de citas: 38 [doi:10.1111/bjh.12390]

  • Odqvist, L; Sanchez-Beato, M; Montes-Moreno, S; Martin-Sanchez, E; Pajares, R; Sanchez-Verde, L; Ortiz-Romero, PL; Rodriguez, J; Rodriguez-Pinilla, SM; Iniesta-Martinez, F; Solera-Arroyo, JC; Ramos-Asensio, R; Flores, T; Palanca, JM; Bragado, FG; Franjo, PD; Piris, MA.

    NIK Controls Classical and Alternative NF-kappa B Activation and Is Necessary for the Survival of Human T-cell Lymphoma Cells

    CLINICAL CANCER RESEARCH. 2013; 19(9): 2319-2330 Nº de citas: 52 [doi:10.1158/1078-0432.CCR-12-3151]

  • Rodriguez-Pinilla, SM; Sanchez, MEC; Rodriguez, J; Garcia, JF; Sanchez-Espiridion, B; Lamana, LF; Sosa, G; Rivero, JC; Menarguez, J; Gomez, IB; Camacho, FI; Guillen, PR; Orduna, CPS; Rodriguez, G; Barrionuevo, C; Franco, R; Mollejo, M; Marco, JF; de Otazu, RD; Piris, MA.

    Loss of TCR-beta F1 and/or EZRIN expression is associated with unfavorable prognosis in nodal peripheral T-cell lymphomas

    Blood Cancer Journal. 2013; 3: Nº de citas: 18 [doi:10.1038/bcj.2013.10]

  • Adema, V; Hernandez, JM; Abaigar, M; Lumbreras, E; Such, E; Calull, A; Dominguez, E; Arenillas, L; Mallo, M; Cervera, J; Marugan, I; Tormo, M; Garcia, F; Gonzalez, T; Luno, E; Sanzo, C; Martin, ML; Fernandez, M; Costa, D; Blazquez, B; Barrena, B; Marco, F; Batlle, A; Buno, I; Martinez-Laperche, C; Noriega, V; Collado, R; Ivars, D; Carbonell, F; Vallcorba, I; Melero, J; Delgado, E; Vargas, MT; Grau, J; Salido, M; Espinet, B; Melero, C; Florensa, L; Pedro, C; Sole, F.

    Application of FISH 7q in MDS patients without monosomy 7 or 7q deletion by conventional G-banding cytogenetics: Does-7/7q-detection by FISH have prognostic value?

    LEUKEMIA RESEARCH. 2013; 37(4): 416-421 Nº de citas: 14 [doi:10.1016/j.leukres.2012.12.010]

  • van de Loosdrecht, AA; Ireland, R; Kern, W; Della Porta, MG; Alhan, C; Balleisen, JS; Bettelheim, P; Bowen, DT; Burbury, K; Eidenschink, L; Cazzola, M; Chu, SSC; Cullen, M; Cutler, JA; Drager, AM; Feuillard, J; Fenaux, P; Font, P; Germing, U; Haase, D; Hellstrom-Lindberg, E; Johansson, U; Kordasti, S; Loken, MR; Malcovati, L; te Marvelde, JG; Matarraz, S; Milne, T; Moshaver, B; Mufti, GJ; Nikolova, V; Ogata, K; Oelschlaegel, U; Orfao, A; Ossenkoppele, GJ; Porwit, A; Platzbecker, U; Preijers, F; Psarra, K; Richards, SJ; Subira, D; Seymour, JF; Tindell, V; Vallespi, T; Valent, P; van der Velden, VHJ; Wells, DA; de Witte, TM; Zettl, F; Bene, MC; Westers, TM.

    Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: position paper of an International Consortium and the European LeukemiaNet Working Group

    LEUKEMIA & LYMPHOMA. 2013; 54(3): 472-475 Nº de citas: 55 [doi:10.3109/10428194.2012.718341]

  • Pelaez, T; Alvarez-Perez, S; Mellado, E; Serrano, D; Valerio, M; Blanco, JL; Garcia, ME; Munoz, P; Cuenca-Estrella, M; Bouza, E.

    Invasive aspergillosis caused by cryptic Aspergillus species: a report of two consecutive episodes in a patient with leukaemia

    JOURNAL OF MEDICAL MICROBIOLOGY. 2013; 62: 474-478 Nº de citas: 37 [doi:10.1099/jmm.0.044867-0]

  • Daikeler, T; Labopin, M; Ruggeri, A; Crotta, A; Abinun, M; Hussein, AA; Carlson, K; Cornillon, J; Diez-Martin, JL; Gandemer, V; Faraci, M; Lindemans, C; O'Meara, A; Mialou, V; Renard, M; Sedlacek, P; Sirvent, A; Socie, G; Sora, F; Varotto, S; Sanz, J; Voswinkel, J; Vora, A; Yesilipek, MA; Herr, AL; Gluckman, E; Farge, D; Rocha, V.

    New autoimmune diseases after cord blood transplantation: a retrospective study of EUROCORD and the Autoimmune Disease Working Party of the European Group for Blood and Marrow Transplantation

    BLOOD. 2013; 121(6): 1059-1064 Nº de citas: 61 [doi:10.1182/blood-2012-07-445965]

  • Font, P; Loscertales, J; Benavente, C; Bermejo, A; Callejas, M; Garcia-Alonso, L; Garcia-Marcilla, A; Gil, S; Lopez-Rubio, M; Martin, E; Munoz, C; Ricard, P; Soto, C; Balsalobre, P; Villegas, A.

    Inter-observer variance with the diagnosis of myelodysplastic syndromes (MDS) following the 2008 WHO classification

    ANNALS OF HEMATOLOGY. 2013; 92(1): 19-24 Nº de citas: 64 [doi:10.1007/s00277-012-1565-4]

  • Kwon, M; Balsalobre, P; Serrano, D; Corral, AP; Buno, I; Anguita, J; Gayoso, J; Diez-Martin, JL.

    Single Cord Blood Combined with HLA-Mismatched Third Party Donor Cells: Comparable Results to Matched Unrelated Donor Transplantation in High-Risk Patients with Hematologic Disorders

    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION. 2013; 19(1): 143-149 Nº de citas: 23 [doi:10.1016/j.bbmt.2012.08.019]

  • Martin-Sanchez, E; Rodriguez-Pinilla, SM; Sanchez-Beato, M; Lombardia, L; Dominguez-Gonzalez, B; Romero, D; Odqvist, L; Garcia-Sanz, P; Wozniak, MB; Kurz, G; Blanco-Aparicio, C; Mollejo, M; Alves, FJ; Menarguez, J; Gonzalez-Palacios, F; Rodriguez-Peralto, JL; Ortiz-Romero, PL; Garcia, JF; Bischoff, JR; Piris, MA.

    Simultaneous inhibition of pan-phosphatidylinositol-3-kinases and MEK as a potential therapeutic strategy in peripheral T-cell lymphomas

    Haematologica-The Hematology Journal. 2013; 98(1): 57-64 Nº de citas: 28 [doi:10.3324/haematol.2012.068510]

  • Vazquez, L; Carreras, E; Serrano, D; Jarque, I; Mensa, J; Barberan, J.

    Antifungal prophylaxis in the haematological patient: a practical approach

    REVISTA ESPANOLA DE QUIMIOTERAPIA. 2012; 25(4): 299-304 Nº de citas: 5

  • Castillo, JJ; Furman, M; Beltran, BE; Bibas, M; Bower, M; Chen, WN; Diez-Martin, JL; Liu, JJ; Miranda, RN; Montoto, S; Nanaji, NM; Navarro, JT; Seegmiller, AC; Vose, JM.

    Human immunodeficiency virus-associated plasmablastic lymphoma: Poor prognosis in the era of highly active antiretroviral therapy

    CANCER. 2012; 118(21): 5270-5277 Nº de citas: 140 [doi:10.1002/cncr.27551]

  • Sanz, J; Boluda, JCH; Martin, C; Gonzalez, M; Ferra, C; Serrano, D; de Heredia, CD; Barrenetxea, C; Martinez, AM; Solano, C; Sanz, MA; Sanz, GF.

    Single-unit umbilical cord blood transplantation from unrelated donors in patients with hematological malignancy using busulfan, thiotepa, fludarabine and ATG as myeloablative conditioning regimen

    BONE MARROW TRANSPLANTATION. 2012; 47(10): 1287-1293 Nº de citas: 114 [doi:10.1038/bmt.2012.13]

  • Alonso, M; Escribano, P; Guinea, J; Recio, S; Simon, A; Pelaez, T; Bouza, E; de Viedma, DG.

    Rapid Detection and Identification of Aspergillus from Lower Respiratory Tract Specimens by Use of a Combined Probe-High-Resolution Melting Analysis

    JOURNAL OF CLINICAL MICROBIOLOGY. 2012; 50(10): 3238-3243 Nº de citas: 17 [doi:10.1128/JCM.00176-12]